Similar articles

• Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients.

  Moroni M, Lazzarin A, Orlando G, Crocchiolo P, Castagna A, Verani P. Moroni M, et al. Chemioterapia. 1987 Jun;6(2 Suppl):639-41. Chemioterapia. 1987. PMID: 3509513 No abstract available.
• AZT given the green light for clinical treatment of AIDS.

  Ezzell C. Ezzell C. Nature. 1987 Apr 2-8;326(6112):430. doi: 10.1038/326430b0. Nature. 1987. PMID: 3470603 No abstract available.
• AIDS file. ddC gets FDA nod.

  Meyer C. Meyer C. Am J Nurs. 1992 Sep;92(9):14. Am J Nurs. 1992. PMID: 1324602 No abstract available.
• [Ribavirin in viral bronchiolitis].

  Tal A, Dagan R. Tal A, et al. Harefuah. 1987 Nov 15;113(10):307-8. Harefuah. 1987. PMID: 3326803 Review. Hebrew. No abstract available.
• Rare diseases, drug development, and AIDS: the impact of the Orphan Drug Act.

  Arno PS, Bonuck K, Davis M. Arno PS, et al. Milbank Q. 1995;73(2):231-52. Milbank Q. 1995. PMID: 7776947 Review.